# Migrasome Therapeutic

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/migrasome-therapeutic

- Industry: Biotechnology
- Headquarters: Beijing, China
- Total disclosed funding: $14M
- Latest round: Angel (Jul 25, 2023)
- Investors on record: 5

## About

Based in Beijing, China, and established in 2022, Migrasome Therapeutic is a biotechnology company that focuses on the R&D of new drugs. The company was established by professor Li Yu, at Life Sciences College, Tsinghua University. In 2012, the professor Li Yu team discovered and named a new organelle, the migrator. In 2015, professor Li Yu published a paper on the Cell Research journal, and reporting on the migrator. In July 2023, Migrasome Therapeutic raised over CNY 100 million in angel+ funding led by new investor Zhongguancun Co-Innovative Fund Management, with participation from other new investors Tsinghua Capital, Qingkong Tiancheng Asset Management, Qihang Capital, and BSTIG.

Migrasome Therapeutic developed engineered drug delivery platforms, migrator-related innovative drugs and diagnostic products. The migrator is membranous organelles produced during cell migration, and natural signal delivery systems in the body. The migrator can be used in the fields of drug delivery, and tumour immunity.

## Funding rounds

- Angel, Jul 25, 2023, $14M — Beijing Capital Science and Technology Development Group Investment Management, Tsinghua Capital, Zhongguancun Co-Innovative Fund Management, Qihang Capital, Qingkong Tiancheng Asset Management

## Investors

- Beijing Capital Science and Technology Development Group Investment Management (https://capitalatlas.ai/funds/beijing-capital-science-and-technology-development-group-inv) — Angel
- Tsinghua Capital — Angel
- Zhongguancun Co-Innovative Fund Management (https://capitalatlas.ai/funds/zhongguancun-co-innovative-fund-management) — Angel
- Qihang Capital (https://capitalatlas.ai/funds/qihang-capital) — Angel
- Qingkong Tiancheng Asset Management (https://capitalatlas.ai/funds/qingkong-tiancheng-asset-management) — Angel